News
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
While a vaccine to prevent HIV still is needed, some experts say the shot — a drug called lenacapvir — could be the next best ...
A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn ...
Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...
The Food and Drug Administration approved a new vaccine to prevent HIV infection, lenacapavir, a long-acting injection, which ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.
Gilead Sciences’ Yeztugo receives nod; the first and only US FDA-approved HIV prevention option offering 6 months of protection: Foster City, California Friday, June 20, 2025, 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results